Drug
Insulin degludec clinical trials
Also written Tresiba and NN1250.
- studies test it
- 127
- open now
- 6
- in phase 3
- 57
- first study started
- 2006
Keep track of what changes. Save the insulin degludec studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Development codes
Studies by the year they started
127 studies that test it; most in 2010 (23)
| Year | Studies |
|---|---|
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 16 |
| 2010 | 23 |
| 2011 | 10 |
| 2012 | 11 |
| 2013 | 10 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 47
- Phase 2
- 4
- Phase 3
- 57
- Phase 4
- 15
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 107 · Other 20
Novo Nordisk A/S (98) · Mannkind Corporation (2) · Ain Shams University (2) · Eli Lilly and Company (2) · Tonghua Dongbao Pharmaceutical Co.,Ltd (2) · Sunshine Lake Pharma Co., Ltd. (1) · Medanta, The Medicity, India (1) · University of Palermo (1)
Often tested with
Tested in the same studies.
Insulin Aspart (39) · Liraglutide (21) · Insulin Glargine (17) · Insulin aspart, insulin aspart protamine drug combination 30:70 (3) · Insulin, Regular, Human (2) · Insulin Lispro (2) · Insulin icodec (1) · Insulin glulisine (1)
Studies
Open first, then newest update. How each study uses insulin degludec is read from its arms, and is right about nine times in ten.
Testing it · 127
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 DiabetesNot yet recruitingPhase 4Yanbing LiNCT07173712Written as Insulin Degludec and Insulin Aspart Injection
- Comparison Study of Insulin GZR4 With Insulin DegludecRecruitingPhase 1Gan and Lee Pharmaceuticals, USANCT07146347Written as GZR4 injection
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingPhase 3Tonghua Dongbao Pharmaceutical Co.,LtdNCT06559722Written as Insulin Degludec/liraglutide Injection
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese SubjectsRecruitingPhase 1Tonghua Dongbao Pharmaceutical Co.,LtdNCT06449703Written as insulin degludec/liraglutide
- Research on Optimal Strategy of Hypoglycemic Therapy for Cirrhosis With DiabetesRecruitingPhase 3Huashan HospitalNCT05641337Written as Insulin Degludec and Insulin Aspart
- A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 DiabetesRecruitingPhase 3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04955834Written as Insulin degludec injection
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)CompletedPhase 3Novo Nordisk A/SNCT04795531Written as Insulin degludec
- A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in ChinaCompletedPhase 3Sunshine Lake Pharma Co., Ltd.NCT05802862Written as Insulin Degludec and Insulin Aspart
- Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 DiabetesCompletedPhase 4Mannkind CorporationNCT05243628Written as insulin degludec
- Degludec Glargine U300 Hospital StudyCompletedNot applicableMedanta, The Medicity, IndiaNCT05036876Written as Degludec
- INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 DiabetesCompletedPhase 4Mannkind CorporationNCT05904743Written as insulin degludec
- Insulin Degludec vs Insulin Glargine for Glycemic Control in Critical Illness HyperglycemiaCompletedNot applicableAin Shams UniversityNCT06178874Written as Insulin Degludec
- Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic InpatientsCompletedPhase 4University of PalermoNCT05360537Written as Insulin Degludec / Liraglutide Injectable Product
- Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2CompletedPhase 2/3Insel Gruppe AG, University Hospital BernNCT03387787Written as Insulin Degludec
- Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 AnalogueStatus unknownPhase 3Hospital Universitario San IgnacioNCT05767255Written as insulin degludec + liraglutide
- Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03377699Written as Insulin degludec
- A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)CompletedPhase 3Novo Nordisk A/SNCT03172494Written as Insulin degludec/liraglutide
- Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.CompletedPhase 4Sansum Diabetes Research InstituteNCT03668808Written as Insulin Degludec
- A Study of LY900014 and Insulin Degludec in Participants With Type 1 DiabetesCompletedPhase 2Eli Lilly and CompanyNCT04585776Written as Insulin Degludec
- Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 DiabetesCompletedPhase 4Emory UniversityNCT03336528Written as Degludec
See all 127 studies that test insulin degludec →
Given in every arm · 28 — insulin degludec is usual care beside what is tested
- A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 DiabetesRecruitingPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT07032688Written as Insulin Degludec Injection
- A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingCompletedPhase 1Novo Nordisk A/SNCT06288412Written as Insulin degludec
- Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With DiabetesCompletedPhase 3Novo Nordisk A/SNCT04588259Written as Insulin degludec
- Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DMCompletedNot applicableBeijing HospitalNCT05417841Written as Insulin Degludec and Insulin Aspart Injection
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2DCompletedPhase 4The Cleveland ClinicNCT04538352Written as Insulin Degludec
- Basal Plus GLP1-ra on Glycemic Variability in CKDCompletedPhase 4Elaine ChowNCT05218915Written as Insulin Degludec
- A Clinical Study of GZR33 and GZR101 in Healthy SubjectsCompletedPhase 1Gan and Lee Pharmaceuticals, USANCT06556641Written as Insulin Degludec
- Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine DoseCompletedPhase 4University of WashingtonNCT04623086Written as Insulin Degludec
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLiraCompletedPhase 3Population Health Research InstituteNCT03862716Written as insulin degludec
- A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT04569994Written as Insulin degludec
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03952130Written as Insulin Degludec
- A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy SubjectsCompletedPhase 1Sunshine Lake Pharma Co., Ltd.NCT05576298Written as Insulin degludec, Tresiba
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03952143Written as Insulin Degludec
- Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT03268005Written as Insulin degludec
- A Study of LY900014 in Participants With Type 1 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03214367Written as Insulin Degludec
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 DiabetesCompletedPhase 3Eli Lilly and CompanyNCT03214380Written as Insulin Degludec
- Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT02500706Written as insulin degludec
- Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT02670915Written as insulin degludec
- Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00972283Written as insulin degludec
- Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesCompletedPhase 3Novo Nordisk A/SNCT00982228Written as insulin degludec
Showing 20 of 28.
As the comparator · 33 — what is tested is compared with insulin degludec
- A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 DiabetesRecruitingPhase 1Eli Lilly and CompanyNCT06945406Written as Degludec SC
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult MalesRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07630233Written as Insulin Degludec Injection
- Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 DiabetesRecruitingPhase 3Gan & Lee Pharmaceuticals.NCT07527078Written as Insulin Degludec Injection (Tresiba®)
- A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)CompletedPhase 1Eli Lilly and CompanyNCT06280703Written as Insulin Degludec
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedPhase 3Novo Nordisk A/SNCT04760626Written as Insulin Degludec
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal InsulinActive, not recruitingPhase 2Eli Lilly and CompanyNCT07215312Written as Degludec
- A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 DiabetesCompletedPhase 1Novo Nordisk A/SNCT06685185Written as Insulin degludec
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinCompletedPhase 3Novo Nordisk A/SNCT04770532Written as Insulin degludec
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)CompletedPhase 3Novo Nordisk A/SNCT04848480Written as insulin degludec
- A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinActive, not recruitingPhase 3Gan & Lee Pharmaceuticals.NCT06767748Written as insulin degludec
- A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic DrugsActive, not recruitingPhase 2Jiangsu HengRui Medicine Co., Ltd.NCT07018453Written as Insulin Degludec
- iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)CompletedPhase 3SanofiNCT05413369Written as IDegAsp
- Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal ImpairmentTerminatedPhase 4SanofiNCT05552859Written as Insulin degludec 100 U/mL
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection TherapyCompletedPhase 3Eli Lilly and CompanyNCT05463744Written as Insulin Degludec
- A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal InsulinCompletedPhase 3Eli Lilly and CompanyNCT05275400Written as Insulin Degludec
- A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeCompletedPhase 3Eli Lilly and CompanyNCT05362058Written as Insulin Degludec
- A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes MellitusCompletedPhase 2Gan and Lee Pharmaceuticals, USANCT06202079Written as Insulin Degludec
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 DiabetesCompletedPhase 1Gan and Lee Pharmaceuticals, USANCT06553248Written as Insulin Degludec
- A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With Type 2 Diabetes MellitusCompletedPhase 1Eli Lilly and CompanyNCT06132126Written as Insulin degludec
- IDegLira HIGH TrialCompletedPhase 3Emory UniversityNCT03737240Written as Insulin Degludec (U-100)
Showing 20 of 33.
Codes
What other systems call insulin degludec · ClinicalTrials.gg INT006051
- MeSH (NLM) C571886insulin degludecConfirmed NLM, Wikidata
- UNII (FDA) 54Q18076QBINSULIN DEGLUDECConfirmed FDA, NLM, Wikidata
- RxNorm 1670007Confirmed FDA, Wikidata
- Wikidata Q16252338Insulin degludecConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C142979Insulin DegludecOne source FDA
- DrugBank DB09564One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C571886 | insulin degludec | Confirmed NLM, Wikidata |
| UNII (FDA) | 54Q18076QB | INSULIN DEGLUDEC | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1670007 | — | Confirmed FDA, Wikidata |
| Wikidata | Q16252338 | Insulin degludec | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C142979 | Insulin Degludec | One source FDA |
| DrugBank | DB09564 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.